Navigating the “Optimal Implantation Depth” With a Self-Expandable TAVR Device in Daily Clinical Practice

Kerstin Piayda,Katharina Hellhammer,Verena Veulemans,Horst Sievert,Sameer Gafoor,Shazia Afzal,Inga Hennig,Matthias Makosch,Amin Polzin,Christian Jung,Ralf Westenfeld,Malte Kelm,Tobias Zeus
DOI: https://doi.org/10.1016/j.jcin.2019.07.048
2020-03-01
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objectives</h3><p>This study sought to predict whether different methods of calculating the implantation depth (ID) influence clinical and hemodynamic outcome reporting in patients undergoing transcatheter aortic valve replacement (TAVR) with a self-expandable device.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Different approaches exist to calculate the ID, which may influence uniform and reliable reporting because the updated Valve Academic Research Consortium (VARC-2) criteria do not provide specific instructions.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>The clinical and hemodynamic outcomes of 258 patients undergoing TAVR with a third-generation self-expandable device were analyzed with regard to the method used to assess the ID as follows: arithmetic mean, the arithmetic mean of the measured distances from the noncoronary cusp and the left coronary cusp to the distal prosthesis end; noncoronary cusp distance, the distance from the noncoronary cusp to the distal prosthesis end; and deepest edge, the deepest edge of the distal prosthesis end.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Regardless of the measurement method, the optimal ID (OID) was reached in &lt;30% (arithmetic mean, 25.4%; noncoronary cusp distance, 28.4%; deepest edge, 20.5%; p = 0.008). The deepest edge method is the most stringent to differentiate the relevant outcome parameters, such as the need for permanent pacemaker implantation (OID 3.7% vs. no OID 14.6%; p = 0.033). The hemodynamic outcome (i.e., mean pressure gradient reduction after TAVR: OID 7.4 ± 3.4 mm Hg vs. no OID 8.3 ± 4.0 mm Hg; p = 0.093) was not affected.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>The OID was reached in &lt;30% of TAVR procedures. The various methods applied for ID calculation significantly influence the outcome reporting and do not allow a uniform perception of the ID. (Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation; <a href="https://clinicaltrials.gov/ct2/show/NCT01805739?term=NCT01805739&amp;rank=1">NCT01805739</a>)</p>
What problem does this paper attempt to address?